High-grade glioma associated immunosuppression does not prevent immune responses induced by therapeutic vaccines in combination with T(reg) depletion

High-grade gliomas (HGG) exert systemic immunosuppression, which is of particular importance as immunotherapeutic strategies such as therapeutic vaccines are increasingly used to treat HGGs. In a first cohort of 61 HGG patients we evaluated a panel of 30 hematological and 34 plasma biomarkers. Then,...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cancer Immunol Immunother
Glavni autori: Löhr, Mario, Freitag, Benjamin, Technau, Antje, Krauss, Jürgen, Monoranu, Camelia-Maria, Rachor, Johannes, Lutz, Manfred B., Hagemann, Carsten, Kessler, Almuth F., Linsenmann, Thomas, Wölfl, Matthias, Ernestus, Ralf-Ingo, Engelhardt, Sabrina, Gelbrich, Götz, Schlegel, Paul G., Eyrich, Matthias
Format: Artigo
Jezik:Inglês
Izdano: Springer Berlin Heidelberg 2018
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6182405/
https://ncbi.nlm.nih.gov/pubmed/30054667
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-018-2214-0
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items